Will J&J Buy A Competitor To Guidant? January 31, 2006 -- Now that Johnson & Johnson has lost its battle for Guidant, where will it go next? If you believe the rumors, the company is looking to bolster its presence in devices. Devices and diagnostics were two of the bright spots in J&J’s most recent quarterly report. It is clear the giant is counting on both of these areas to bolster its sagging pharma sales. We look at the likely targets--St. Jude and Edwards--examining what each one has to offer...
